Concepedia

Kelly M. Rausch

KM

32

Publications

2.3K

Citations

24

H-Index

2001

Active since

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Vector Oncology (United States)

Johns Hopkins University

Karolinska Institutet

Kelly M. Rausch is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, vaccination, and malaria.

ORCID

Top concepts

Publications per year

2001–2024

32

Publications

32

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

Yimin Wu, Ruth D. Ellis, Donna Shaffer et al. · PLoS ONE · 2008 · 450 citations · Full text

Composite Active Site of an ABC ATPase

M.S. Junop, Galina Obmolova, Kelly M. Rausch et al. · Molecular Cell · 2001 · 264 citations · Full text

, , +5

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults

Kawsar R. Talaat, Ruth D. Ellis, Janet Hurd et al. · PLoS ONE · 2016 · 135 citations · Full text

, , +20

Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230

Nicholas J. MacDonald, Vu Nguyen, Richard L. Shimp et al. · Journal of Biological Chemistry · 2016 · 107 citations · Full text

Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice

Sara A. Healy, Charles Anderson, Bruce Swihart et al. · Journal of Clinical Investigation · 2021 · 106 citations · Full text

Rows per page

1–5 of 32